Binimetinib,Ipatasertib,Nilotinib,Olaparib,Palbociclib,Panitumumab,Selumetinib,Sotorasib
Pfizer,Roche,Novartis,inhibikase,Merck,Amgen,Astrazeneca
[]
 nci-combomatch aims to overcome drug resistance and improve treatment efficacy by developing genomically-directed combination therapies
#cancerresearch #precisionmedicine #aacr23 
On the road! Pursuing to improve global health through sharing knowledge, cancer prevention, and care. Professor, Medical oncologist @AnkaraUni